SMTL ID : 6qb4.1

Mcl1-scFv complex with an indole acid inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.38 Å

Oligo State

hetero-1-1-mer

Ligands

1 x HVN: 3-[3-[[(1~{R})-1,2,3,4-tetrahydronaphthalen-1-yl]oxy]propyl]-7-(1,3,5-trimethylpyrazol-4-yl)-1~{H}-indole-2-carboxylic acid(Non-covalent)

HVN.1: 11 residues within 4Å: Chain A: H.59, A.62, L.70, V.84, M.85, V.88, R.98, T.101, L.102, F.105, G.106 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.70, A:V.84, A:T.101, A:F.105 Salt bridges: A:R.98 pi-Stacking: A:F.105, A:F.105

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Luptak, J. et al., Antibody fragments structurally enable a drug-discovery campaign on the cancer target Mcl-1. Acta Crystallogr D Struct Biol (2019)

Release Date

2019-11-06

Peptides

Induced myeloid leukemia cell differentiation protein Mcl-1: A
scFv55: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
X

Induced myeloid leukemia cell differentiation protein Mcl-1

scFv55

Related Entries With Identical Sequence